Neuroscience company Cognivue enrolled more than double the national average participation rate of diverse populations in its Further the Objective and Clinical Understanding of Cognivue Study (FOCUS) study. Velocity supported the study by enrolling the entirety of the study’s more than 1,500 subjects across 14 sites and 11 states.
While typical studies of this size average between 2% and 16% participation of diverse populations, 37% of the subjects in the FOCUS study were members of historically underserved and underrepresented populations.
